Depression in Pediatric and Adolescents

January 06, 2017

Location: Hartford Hospital's Institute of Living

The Burlingame Center for Psychiatric Research and Education is currently recruiting patients 7-17 years of age for a double-blind, clinical trial using Vilazodone for the treatment of pediatric and adolescent major depressive disorder. After completion of the 8-week study, subjects are eligible for a 6-month open-label trial of Vilazodone.

For more information about this trial, please contact:

Dr. Salma Malik
Phone: 860.545.7502
Email: clinical.trials@hhchealth.org